Found: 8
Select item for more details and to access through your institution.
Weak D phenotypes and transfusion safety: where do we stand in daily practice?
- Published in:
- Transfusion, 2007, v. 47, n. 9, p. 1616, doi. 10.1111/j.1537-2995.2007.01332.x
- By:
- Publication type:
- Article
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis.
- Published in:
- Comparative Hepatology, 2005, v. 4, p. 10, doi. 10.1186/1476-5926-4-10
- By:
- Publication type:
- Article
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C.
- Published in:
- Comparative Hepatology, 2004, v. 3, p. 8, doi. 10.1186/1476-5926-3-8
- By:
- Publication type:
- Article
Mutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM.
- Published in:
- 1998
- By:
- Publication type:
- letter
Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center.
- Published in:
- Catheterization & Cardiovascular Interventions, 2012, v. 79, n. 1, p. 104, doi. 10.1002/ccd.23164
- By:
- Publication type:
- Article
Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention.
- Published in:
- Catheterization & Cardiovascular Interventions, 2011, v. 77, n. 2, p. 182, doi. 10.1002/ccd.22674
- By:
- Publication type:
- Article
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.
- Published in:
- 2004
- By:
- Publication type:
- Correction notice
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2004, v. 42, n. 3, p. 323
- By:
- Publication type:
- Article